Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Maxine D Fisher"'
Publikováno v:
Future Oncology.
Aim: Real-world data on treatment patterns and outcomes of advanced ovarian cancer (OC) patients since bevacizumab approval in first-line (1L) OC treatment were assessed. Materials & methods: In this descriptive retrospective study using the ConcertA
Autor:
Santosh Gautam, Anna Vlahiotis, Maxine D. Fisher, Kendra DeBusk, Gregory A. Vidal, Sonia Pulgar
Publikováno v:
Future Oncology. 18:849-858
Aim: To describe real-world treatment patterns/outcomes among patients with HER2+ metastatic breast cancer (MBC). Materials & methods: Real-world treatments and overall survival (OS) were evaluated among adult women diagnosed with HER2+ MBC, with and
Autor:
Kevin M Kalinsky, Megan Kruse, Emily Nash Smyth, Claudia M Guimaraes, Santosh Gautam, Alnecia R Nisbett, Maxine D Fisher, Zhanglin Lin Cui, Lee Bowman
Publikováno v:
Cancer Research. 82:P1-18
Background: Cyclin-dependent kinase 4 and 6 inhibitors (CDK4 & 6i) provide significant benefit for patients (pts) with HR+, HER2- MBC, however, clinical questions remain regarding the optimal sequence (seq) of treatments (tx). Prior analyses of real
Publikováno v:
Future Oncology. 17:1879-1887
Background: There is limited real-world information on use of tumor mutational burden (TMB) testing and characteristics of patients receiving it. Materials & methods: Patients ≥18 years old and diagnosed with advanced solid tumors between 1 January
Autor:
Junji Lin, Maxine D. Fisher, Lynn McRoy, Mark S. Walker, Cralen Davis, Nan Hu, Debanjali Mitra
Publikováno v:
Future Oncology. 17:1001-1011
Background: Limited studies have evaluated palbociclib-based therapy use in patients with advanced/metastatic breast cancer in the real world. This retrospective study used medical records from US community oncology practices to address the gap. Mate
Publikováno v:
Journal of comparative effectiveness research. 10(10)
Aim & methods: This real-world study examined the association of tumor mutational burden (TMB) with clinical and healthcare utilization in adults diagnosed with advanced solid tumor 1 January 2015– 31 January 2019. Results: There were 170 patients
Publikováno v:
Clinical Genitourinary Cancer. 16:e1171-e1179
Current real-world data regarding treatment patterns in advanced bladder cancer in the community setting are limited. This study describes patient characteristics, treatment patterns, and effectiveness outcomes for stage IV bladder cancer in the comm
Autor:
Moon Fenton, Temitope Olufade, Maxine D. Fisher, Ancilla W. Fernandes, Mark S. Walker, Paul J. E. Miller
Publikováno v:
Clinical Therapeutics. 40:1522-1537
Purpose The purpose of this study was to provide an understanding of the effectiveness of existing therapies in patients with advanced head and neck cancer (HNC), particularly in clinical practice. Methods Data from the electronic medical records of
Publikováno v:
Value in Health. 24:S24
Autor:
Jay Schukman, Arthur Small, Maxine D. Fisher, Jennifer Malin, Rajeshwari S. Punekar, Rakesh Luthra, Barbara L. McAneny, Yeun Mi Yim, Joseph Singer
Publikováno v:
Journal of Oncology Practice. 13:e37-e46
Purpose: The current shift in site of care from community oncology practices to the hospital outpatient department to deliver oncology services may have significant implications for the economic and clinical outcomes of cancer care. Therefore, this s